awaters+FollowBiotech Breakthrough: Epilepsy Drug Fast-Tracked!Here’s a money lifehack for anyone following health tech: Praxis just hit pause on their epilepsy drug trial early—not because of problems, but because the results were so good, they’re heading straight to the FDA. If you or someone you know deals with tough-to-treat seizures, this could mean faster access to new meds. The buzz? Investors are eyeing big future sales, but for families, it’s about hope arriving sooner than expected. #Business #Industry #HealthBreakthrough00Share
